Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (13422)	9/5/2001 4:23:58 PM
From: RockyBalboa	Read Replies (2) \| Respond to of 19633

Tom, Machrochem's Topligan works! Lol....read it here: (will produce a nice pop in the stock too...) biz.yahoo.com early results from the Phase 3 study show that, at the end of the treatment period, more patients using Topiglan than control were able to reach a grade 3 or 4 erection, and were therefore able to obtain adequate rigidity for vaginal penetration. A grade 4 erection is defined as maximum rigidity on a 0 to 4 point scale. However, the study showed positive direction but not statistical significance in the ability to maintain erection to completion of intercourse, a benchmark typically required for approval of an ED drug.